Editors: Atta-ur-Rahman , M. Iqbal Choudhary

Frontiers in Anti-Infective Drug Discovery

Volume 4

eBook: US $109 Special Offer (PDF + Printed Copy): US $185
Printed Copy: US $131
Library License: US $436
ISSN: 2451-9162 (Print)
ISSN: 1879-663X (Online)
ISBN: 978-1-68108-083-3 (Print)
ISBN: 978-1-68108-082-6 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810808261150401


This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The fourth volume of this series features 5 chapters that cover the following topics:

  • - An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
  • - Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
  • - New antibacterial drug targets such as polysaccharide deacetylases
  • - Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
  • - A review of new chemotherapeutic agents against common infections.

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.


- Pp. i-ii (2)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

List of Contributors

- Pp. iii-iv (2)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

Resistance to FDA Licensed Anti-Neuraminidase Drugs Used for Flu Treatment in the Americas: An Overview of the Incidence of Resistant-Strains of Seasonal and Pandemic Influenza Viruses from 2004 to 2014

- Pp. 3-30 (28)
L.A.M.G. Fornells, J.N.S.S. Couceiro
View Abstract

Antidepressants Used as Chemotherapy for Trypanosoma cruzi Infection: Phenothiazines and Derivative Compounds

- Pp. 31-67 (37)
Patricia Paglini Oliva, Silvina Lo Presti, Walter Rivarola
View Abstract

Polysaccharide Deacetylases: New Antibacterial Drug Targets

- Pp. 68-130 (63)
Stavroula Balomenou, Sofia Arnaouteli, Dimitris Koutsioulis, Vasiliki E. Fadouloglou, Vassilis Bouriotis
View Abstract

Targeting RNA with Aminoglycosides: Current Improvements in their Synthesis and Biological Activity

- Pp. 131-209 (79)
Andrés G. Santana, Sandra G. Zárate, Agatha Bastida, Julia Revuelta
View Abstract

New Chemotherapeutic Agents against Common Infections: Clinical Studies on New Anti-Infective Agents

- Pp. 210-229 (20)
Ana García-Robles, Virginia Bosó-Ribelles, Eva Romá-Sánchez, José Luis Poveda-Andrés
View Abstract


- Pp. 230-238 (9)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free


.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).